Insmed reported $29.48M in Trade Debtors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
DBV Technologies DBVT:US 8.21M 3.7M
Acelrx Pharmaceuticals ACRX:US $ 364K 180K
Alimera Sciences ALIM:US $ 20.32M 1.54M
Biomarin Pharmaceutical BMRN:US $ 466.51M 36.36M
Cytokinetics CYTK:US $ 1.97M 4.08M
Dynavax Technologies DVAX:US $ 174.24M 37.31M
Gilead Sciences GILD:US $ 4118M 331M
Heron Therapeutics HRTX:US $ 40.3M 0.8M
Insmed INSM:US $ 29.48M 3.76M
Mirati Therapeutics MRTX:US $ 1.53M 0.28M
Novartis NVS:US $ 8910M 232M
Regeneron Pharmaceuticals REGN:US $ 5161.4M 322.4M
Sarepta Therapeutics SRPT:US $ 230.28M 33.07M
Seattle Genetics SGEN:US $ 438.04M 37.03M
Ultragenyx Pharmaceutical RARE:US $ 37.21M 8.84M
Vertex Pharmaceuticals VRTX:US $ 1332.9M 40.1M